Association between the Use of Proton Pump Inhibitors and Cognitive Impairment in Older Adults

Objetivo: Describir la asociación entre la presencia de alteración cognoscitiva y el uso de inhibidores de la bomba de protones (IBP) en la población adulta mayor de Bogotá, Colombia. Métodos: Se analizaron los datos del estudio SABE-Bogotá, que incluyó 2.000 personas mayores de 60 años de edad, en una muestra transversal probabilística por conglomerados. La variable de interés fue la alteración en el Mini-Mental State Examination Modificado (MMSE-M), la cual se relacionó con el uso de IBP, ajustado por factores como sexo, edad, escolaridad y estado civil. Resultados: La edad promedio fue de 71,17±8,05 años, y el 63,4 % eran mujeres. El consumo de IBP se encontró en el 20,7 % de la población estudiada, con un tiempo de uso promedio en meses de 74,8±93,76. El 12,6 % tenía el MMSE-M alterado, siendo mayor la prevalencia en los consumidores de IBP (25,4 % vs. 20,02 %; p= 0,049). En el análisis multivariado se encontró una asociación de aumento de riesgo ajustado entre el deterioro cognitivo y el uso de IBP por ≥ 24 meses (OR: 1,90; IC: 1,11-3,24; p = 0,018). Conclusiones: Este estudio muestra una asociación de aumento de riesgo significativa entre deterioro cognitivo y el consumo de IBP durante ≥ 24 meses. Se necesitan más estudios que permitan concluir una relación directa de causalidad.Artículo original1-6Objective: The aim of this study was to describe the association between the presence of cognitive impairment and the consumption of proton pump inhibitors (PPI) in community-dwelling older adults from Bogotá, Colombia. Materials and methods: The SABE Bogotá study was analyzed. This study included 2000 people over 60 years, in a cross-sectional sample. The variable of interest was the alteration in the modified Mini-Mental State Examination (MMSE-M). It was related to the use of PPIs. This analysis was adjusted for factors such as sex, age, years of education and marital status. Results: The average age was 71.17 ± 8.05 years, 63.4% were women. The PPIs consumption was found in 20.7%, with an average usage time of 74.8 ± 93.76 months. 12.6% older adults had MMSE-M altered, with a higher prevalence in PPIs consumers (25.4% vs. 20.02%; p: 0.049). In the multivariate analysis, an association of increased risk was found between cognitive deterioration and the use of PPIs for ≥ 24 months (OR: 1.90; IC: 1.11-3.24; p = 0.018). Conclusions: This study shows an association of a significant risk increase between consuming PPIs for ≥ 24 months and having cognitive impairment. More studies are needed to conclude a direct causality relationship

A Frailty Index from Next-of-Kin Data: A Cross-Sectional Analysis from the Mexican Health and Aging Study

Objectives. To construct a frailty index from next-of-kin information of the last year of life of community-dwelling 50 years old or older adults and test its association with health services utilization. Methods. Cross-sectional analysis from next-of-kin data available from the last wave of the Mexican Health and Aging Study (MHAS). Measurements. Along with descriptive statistics, the frailty index (FI) was tested in regression models to assess its association with adverse outcomes previous to death: number of hospitalized days in the previous year and number of visits to a physician in the previous year, in unadjusted and adjusted models. Results. From a total of 2,649 individuals the mean of age was 74.8 (±11.4) and 56.3% (n = 1,183) were women. The mean of the FI was of 0.279 (±SD 0.131, R = 0.0–0.738) and distribution was biased to the right. There was a significant association (p < 0.001) between the FI and number of hospitalized days (β = 45.7, 95% CI 36.1–55.4, p < 0.001) and for the number of visits to a physician (β = 25.93, 95% CI 19.27–32.6, p < 0.001) both models adjusted for age and sex. Conclusion. The FI constructed with next-of-kin data showed similar characteristics to similar indexes of older adults. It was independently associated with health care use

Mortality and associated risk factors for older adults admitted to the emergency department: a hospital cohort

Abstract Background Older emergency department patients are more vulnerable than younger patients, yet many risk factors that contribute to the mortality of older patients remain unclear and under investigation. This study endeavored to determine mortality and factors associated with mortality in patients over 60 years of age who were admitted to the emergency departments of two general hospitals in Mexico City. Methods This is a hospital cohort study involving adults over 60 years of age admitted to the emergency department and who are beneficiaries of the Mexican Institute of Social Security and residents of Mexico City. All causes of mortality from the time of emergency department admission until a follow-up home visit after discharge were measured. Included risk factors were: socio-demographic, health-care related, mental and physical variables, and in-hospital care-related. Survival functions were estimated using Kaplan-Meier curves. Hazard ratios (HR) were derived from Cox regression models in a multivariate analysis. Results From the 1406 older adults who participated in this study, 306 (21.8%) did not survive. Independent mortality risk factors found in the last Cox model were age (HR = 1.02, 95% CI, 1.005–1.04; p = 0.01), length of stay in the ED (HR = 1.003, 95% CI = 0.99, 1.04; p = 0.006), geriatric care trained residents model in Hospital A (protective factor) (HR = 0.66, 95% CI = 0.46, 0.96; p = 0.031), and the FRAIL scale (HR of 1.34 95% CI, 1.02–1.76; p = 0.033). Conclusions Risk factors for mortality in patients treated at Mexican emergency departments are length of stay and variables related to frailty status